Introduction-99m Tc(CO) 3 -nitrilotriacetic acid, 99m Tc(CO) 3 (NTA), is a new renal tubular agent with pharmacokinetic properties comparable to those of 131 I-OIH but the clearance of 99m Tc(CO) 3 (NTA) and 131 I-OIH are still less than the clearance of PAH, the gold standard for the measurement of effective renal plasma flow. At physiological pH, dianionic 99m Tc(CO) 3 (NTA) has a mononegative inner metal-coordination sphere and a mononegative uncoordinated carboxyl group. To evaluated alternate synthetic approaches, we assessed the importance of an uncoordinated carboxyl group, long considered essential for tubular transport, by evaluating the pharmacokinetics of three analogs with the 99m Tc(CO) 3 (NTA) metal-coordination sphere but with uncharged pendant groups.
Introduction
Non-invasive renal scintigraphy has an important role in the determination of relative and absolute renal function and in the evaluation of patients with suspected obstruction or renovascular hypertension. The accuracy of scan interpretation and camera-based measurements of renal function are optimized by a high renal extraction efficiency, providing a rapid renal clearance and high target-to-background ratio. Because only 20% of renal plasma flow in humans is filtered, the extraction efficiency of glomerular filtration rate (GFR) tracers such as 99m Tc-diethylenetriaminepentaacetic acid ( 99m Tc-DTPA) cannot be greater than 20%; consequently, to achieve a high extraction efficiency, it is necessary to design new tracers that are extracted by the renal tubules in a manner similar to that for 131 Io-iodohippurate ( 131 I-OIH), the radioactive standard for the measurement of effective renal plasma flow (ERPF) [1] [2] [3] . 99m Tc-based renal agents have attracted the most interest owing to the widespread availability of 99m Tc and its superior nuclear medicine properties (t 1/2 = 6 h, 140 keV γ-radiation) over the beta emission, 8-day half-life and 364 keV photon of 131 I. 99m Tc-mercaptoacetyltriglycine ( 99m Tc-MAG3) is currently the best available commercial replacement for 131 I-OIH, and it is used in approximately 70% of all radionuclide renal scans performed in the United States [4] [5] [6] [7] . 99m Tc-MAG3 is almost exclusively cleared from plasma by the tubular secretion and by the same organic anion transporter (OAT1) system as 131 I-OIH [8, 9] , although its clearance in humans is only ~ 60% that of 131 I-OIH [4, 5] . A number of other alternatives have been proposed over the decades, including 99m Tc-ethylenedicysteine ( 99m Tc-EC) [10, 11] and 99m Tcmercaptoacetamide-ethylenecysteine ( 99m Tc-MAEC) [12] ; the 99m Tc-EC and 99m Tc-MAEC renal clearances exceed that of 99m Tc-MAG3 but are still lower than that of 131 I-OIH. 99m Tc-MAG3, 99m Tc-EC and 99m Tc-MAEC all have a 99m Tc V O core and a dangling arm with a carboxyl group, which is deprotonated at physiological pH, giving the complexes a dianionic overall charge. The negatively charged uncoordinated carboxyl group has been postulated to be a critical structural component essential for recognition of the tracer by the OAT1 tubular transporter receptor localized at the basolateral membrane of the proximal tubules [8, 13, 14] . Attempts to determine other features important for recognition by the OAT1 transporter included the preparation of a number of 99m Tc-MAG3 analogs to assess the effect of modification of the backbone structure of the MAG3 ligand to further elucidate the structural requirements for an efficient tubular transport. These analogs include the diamide [15] , triamide [16] , and oxamide [17] derivatives of MAG3, ones with a methyl substituent on the glycine moieties of MAG3 [18] , and ones obtained by replacement of one or more glycyl groups of MAG3 by other amino acids [19, 20] . Animal studies showed that some of these 99m Tc-MAG3-analogs were cleared rapidly from the blood and excreted into the urine, closely resembling the biological behavior of 99m Tc-MAG3, but none of them exhibited better renal kinetics than 99m Tc-MAG3. It should be pointed out that all of these 99m Tc-MAG3 analogs contained an uncoordinated carboxyl group, a structural component considered to be essential for rapid renal clearance. In contrast, two 99m Tc-MAG3 derivatives, in which the free carboxyl group of MAG3 was replaced with a larger group, a mononegative sulfonate or a dinegative phosphonate group, were evaluated to determine the effect of charge distributed over a larger group and of total charge on tubular transport [21] . These two 99m Tc-MAG3 derivatives had a 40-50% lower clearance compared to that of 99m Tc-MAG3, suggesting that the difference in charge is not the critical factor in tubular transport but that a larger size of the dangling negative group may decrease renal excretion.
More recently, a completely new class of renal tracers based on the 99m Tc I (CO) 3 core and highly hydrophilic ligands has been developed and evaluated in rats; ligands examined in such 99m Tc-tricarbonyl tracers include nitrilotriacetic acid [in 99m Tc(CO) 3 [26] , and carboxymethylthioethyliminodiacetic acid [in 99m Tc(CO) 3 (CMT-IDA)] [27] . The 99m Tc(CO) 3 (NTA), 99m Tc(CO) 3 (ASMA) and 99m Tc(CO) 3 (CMSA) tracers were rapidly extracted by the kidney and eliminated in the urine in rats almost as fast as 131 I-OIH [22] [23] [24] . These three 99m Tc-tricarbonyl tracers have a negatively charged inner coordination sphere and a dianionic overall charge at physiological pH [24, 28, 29] ; in addition, they also contain the free carboxylate group found in 99m Tc-MAG3, 99m Tc-EC and 99m Tc-MAEC and the other 99m Tc V O renal tracers. Furthermore, 99m Tc(CO) 3 (NTA) has been shown to have pharmacokinetic properties comparable to those of 131 I-OIH in normal volunteers [30] and also in patients with severely reduced renal function [31] .
To better assess the importance of a negatively charged uncoordinated carboxyl group for OAT1 transporter recognition and tubular secretion, we conducted a series of studies in rats to evaluate the pharmacokinetics of three new monoanionic 99m Tc(CO) 3 (NTA) analogs with uncharged pendant groups but with inner coordination spheres identical to that in 99m Tc(CO) 3 (NTA) (Figure 1 ). 3 ]OTf was prepared as previously reported [32] . Re(CO) 3 (ADA) and Re(CO) 3 (HDA) were synthesized as nonradioactive reference compounds as previously described [29] . All other reagent-grade chemicals and solvents were obtained from commercial suppliers and used without further purification. 1 H/ 19 F NMR spectra were recorded on a Varian 400 MHz spectrometer, and chemical shifts are reported in δ units using the residual solvent peak as reference; electrospray mass spectrometry (ESI-MS, negative mode) was performed on a Thermo Finnigan LTQ-FT instrument. 99m , a flow rate was 1 mL/min, and the gradient methods used were the same as reported previously [24] . Tissue/organ radioactivity was measured with an automated 2480 Wizard 2 gamma counter (Perkin Elmer) that corrects for spillover from 131 I into the 99m Tc window based on a prior normalization process.
Materials and methods
All animal experiments followed the principles of laboratory animal care and were approved by the Institutional Animal Care and Use Committee of Emory University.
Note: all specific 99m Tc(CO) 3 complexes mentioned in this work have a facial geometry; therefore, the facdesignation is omitted. Also, the M(CO) 3 (L) nomenclature (M = 99m Tc, Re; L = ligand) is used as a general reference to the 99m Tc and Re complexes, whereas a specific form defied is designated as [M(CO) 3 (L)] − (monoanion).
Chemistry

Dimethyl N-(2-fluoroethyl)iminodiacetate (5)-Dimethyl iminodiacetate
hydrochloride (1 g, 5.0 mmol) and 1-bromo-2-fluoroethane (0.63 g, 5.0 mmol) were combined with acetonitrile (5 mL) and diisopropylamine (1.2 mL, 11 mmol) in an ovendried 10 mL sealed tube. The tube was heated in an oil bath at 90 °C for 3 d. The reaction mixture was concentrated, and the crude yellow solid was purified by flash chromatography (97% CHCl 3 , 3% MeOH) to yield the product as a slightly yellow oil (0.77 g, 74%), which was used for subsequent reaction without further purification. 1 
N-(2-fluoroethyl)iminodiacetic acid (FEDA, 4)-Compound 5
(80 mg, 0.4 mmol) was dissolved in 80 µL of methanol before the addition of 2 M NaOH (400 µL). TLC of the reaction mixture (dichloromethane : methanol, 9:1) already showed both the product (Rf = 0) and the starting material (Rf = 0.9) in under a minute. The solution was stirred at room temperature for 1 h to ensure reaction completion and loaded directly onto a C18 reverse phase flash column without concentrating or neutralizing the ligand. The product was eluted with water into 4 mL fractions, and was found in fraction 10, as evidenced by the brown stain observed by spotting on TLC and dipping in a basic permanganate solution. The fraction was concentrated to give the pure product as a colorless oil (46 mg, 63%). 1 
99m Tc radiolabeling
ADA, HDA and FEDA ligands were labeled in a similar manner to form 99m Tc-tricarbonyl complexes as previously described for the NTA ligand [22] . Briefly, a freshly prepared solution of the [ 99m Tc(CO) 3 
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Biodistribution studies in rats
The biodistribution of 99m Tc(CO) 3 (ADA) ( 99m Tc-2), 99m Tc(CO) 3 (HDA) ( 99m Tc-3) and 99m Tc(CO) 3 Animals were sacrificed at 10 min and 60 min after injection. Tissues of interest, along with blood and urine, were collected and placed in counting vials. Each sample and the standards were counted for radioactivity by using an automated gamma-counter using the 99m Tc/ 131 I dual-label program. The percentage of the dose in each tissue or organ was calculated by dividing the counts in each tissue or organ by the total injected counts. The percentage injected dose in whole blood was estimated by assuming a blood volume of 6.5% of total body weight.
One rat in each of the 60 min studies of 99m Tc(CO) 3 (ADA), 99m Tc(CO) 3 (HDA), and 99m Tc(CO) 3 (FEDA) produced very little urine, and two rats in the 10 min study of 99m Tc(CO) 3 (ADA) and one rat in the 10 min study of 99m Tc(CO) 3 (HDA) did not produce urine at all; these six rats probably became hypotensive during anesthesia. All six were eliminated from the combined data analysis even though the urine collected from the rats in the 60 min studies had a high 99m Tc/ 131 I ratio ranging from 97-101%.
Metabolism studies
Two additional rats received an intravenous tail vein bolus injection of ~18 MBq of each 99m Tc complex. The bladder was catheterized as described for the biodistribution study, and urine was collected for 15 min, filtered with a 0.2 µm Millex-LG filter to remove foreign particles and analyzed by reversed phase HPLC to determine whether the complex was metabolized or excreted unchanged in the urine.
Plasma protein binding and erythrocyte uptake
Carotid artery blood samples were obtained at 10 min after intravenous injection of each 99m Tc tracer (~100 µCi) and the collected blood samples were immediately centrifuged for 15 min. One milliliter of plasma from the carotid artery sample was used to determine plasma protein binding (PPB) by ultrafiltration (Centrifree micropartition system; Amican Inc.): PPB = [1 -(ultrafiltrate concentration/plasma concentration)] × 100. The blood samples were also placed in capillary tubes and centrifuged to determine the hematocrit. The percent erythrocytes uptake was calculated from the activity counted in the whole blood (counts/g) and packed cells (counts/g) as [(counts/g in erythrocytes × hematocrit)/counts/g in whole blood]. No correction was made for plasma trapped in the red blood cells sample. PPB and erythrocyte uptake were calculated in duplicate and the mean values reported. 
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Author Manuscript Figure 1 shows the general structures of ligands 1-4 and their 99m Tc/Re tricarbonyl complexes ( 99m Tc-1 to 99m Tc-4 and Re-1 to Re-4, respectively). The Re complexes were prepared as nonradioactive reference compounds and for chemical characterization of their analogous 99m Tc tracers since Re and 99m Tc complexes have essentially identical coordination parameters and physical properties. We have previously reported extensive solution and solid-state studies of Re(CO) 3 (NTA) (Re-1) and its analogs with the ADA and HDA ligands (Re-2 and Re-3, respectively) [29] ; here we present the synthesis and characterization of a new Re(CO) 3 complex with the FEDA ligand, Re-4.
Results and discussion
Chemistry
The FEDA ligand (4) was prepared in good yield (68%) by the N-alkylation reaction of dimethyl iminodiacetate with 1-bromo-2-fluoroethane followed by the basic hydrolysis of the methyl ester groups in 5 (Scheme 1). Standard characterization techniques were used to confirm the structure of the isolated material as the desired compound 4 (see the Supporting Information). Reaction of 4 with the [Re(CO) 3 (H 2 O) 3 ] + precursor at 70 °C in the mildly acidic (pH ~ 6) aqueous conditions produced the Re(CO) 3 (FEDA) complex (Re-4) in a moderate yield (50%, Scheme 1).
The molecular structure of the [Re(CO) 3 (FEDA)] − anion (Figure 2 ), confirming the coordination environment of Re-4, was established through single-crystal X-ray analysis. The complex crystallized in the triclinic space group P-1, with two chemically equivalent Na[Re(CO) 3 (FEDA)] molecules bridged by Na + ions. As expected, the structure of Re-4 revealed the tridentate facial coordination of the FEDA ligand to the metal core, with the ONO donor set forming two five-membered chelate rings, and leaving the uncharged fluoroethyl group dangling. This distorted octahedral complex has a negatively charged inner metal-coordination sphere, [Re(CO) 3 (N(CH 2 COO) 2 )] − , identical to that present in the previously reported Re-tricarbonyl complexes with NTA, ADA and HDA (Re-1, Re-2, and Re-3, respectively, Figure 1 ) [29] . All bond lengths and angles fall within expected values and are comparable to those reported for other octahedral complexes containing the [Re(CO) 3 ] + core and the same donor atoms [29, [38] [39] [40] . Crystallographic details, bond lengths and angles, are given in the Supporting Information (Tables S1-S2). As anticipated, the 1 H and 19 
Radiochemistry
The 99m Tc(CO) 3 (ADA) ( 99m Tc-2), 99m Tc(CO) 3 (HDA) ( 99m Tc-3), and 99m Tc(CO) 3 (FEDA) ( 99m Tc-4) radiotracers were synthesized in high yield (>90%) and in a similar manner as was previously reported for 99m Tc(CO) 3 (NTA) ( 99m Tc-1) (Scheme 2) [22] . Formation of each 99m Tc tracer was analyzed by reversed phase HPLC utilizing a radiometric (γ) detector. Each radiotracer was purified by gradient HPLC and obtained as a single product with radiochemical purity > 99%. The chemical identity of each 99m Tc radiotracer was verified by comparing its HPLC retention time (γ detector) to that of a co-inj ected and well-characterized Re analog (determined by using a UV detector; Table 1 ). Both 99m Tc and Re complexes showed similar retention times when co-injected, confirming the formation of the same product at the n.c.a ( 99m Tc) and macroscopic levels (Re) .
The in vitro stability of 99m Tc-2, 99m Tc-3, and 99m Tc-4 in aqueous solution at physiological pH was assessed at various time intervals by HPLC for up to 24 h, and no measurable decomposition or reoxidation to 99m TcO 4 -was observed, which was in close agreement with the findings for their highly stable Re analogs [29] .
Animal studies
The biodistribution studies of 99m Tc(CO) 3 (ADA) ( 99m Tc-2), 99m Tc(CO) 3 (HDA) ( 99m Tc-3), and 99m Tc(CO) 3 (FEDA) ( 99m Tc-4) in normal rats were performed by simultaneous intravenous administration of the 99m Tc radiotracer along with 131 I-OIH, followed by analysis of radioactivity in various organs at 10 and 60 min post injection. 131 I-OIH served as an internal control because it is the radioactive standard for measurement of ERPF. The results are summarized in Table 2 and are expressed as a percent of injected dose (%ID) per organ. For comparison, we have included our previously published biodistribution data for 99m Tc(CO) 3 (NTA) ( 99m Tc-1) [22] . All three new tridentate coordinated 99m Tc(CO) 3 complexes ( 99m Tc-2 to 99m Tc-4) are efficiently excreted from all organs and tissues through the urinary pathway. The blood clearance was rapid for all three 99m Tc tracers, with percent injected dose remaining in the blood ranging from 3.2 ± 0.1% to 5.1 ± 0.9% at 10 min and 0.3 ± 0.2% to 0.6 ± 0.3% at 60 min; these values are comparable to the percent dose in the blood of 99m Tc(CO) 3 (NTA) at the same time points, 4.2 ± 0.9% and 0.4 ± 0.2%, respectively. 99m Tc-2, 99m Tc-3 and 99m Tc-4 were all rapidly eliminated in the urine and demonstrated high specificity renal excretion (Figure 3 ). The activity in the urine as a percentage of 131 I-OIH at 10 and 60 min post injection was 96 ± 2% and 99 ± 1% for 99m Tc-2, 96 ± 3% and 100 ± 1% for 99m Tc-3, and 100 ± 4% and 99 ± 2% for 99m Tc-4, respectively, vs. 108 ± 9% and 101 ± 5%, respectively, for 99m Tc(CO) 3 (NTA) ( 99m Tc-1) [22] . The percent of the injected dose present in the liver at 10 min post-injection was similar, ~ 6%, for each of the three new 99m Tc tracers and ranged from 0.8 ± 0.1% to 2.1 ± 0.5% at 60 min, values only minimally higher than the liver activity of 99m Tc(CO) 3 (NTA) at the same time points. Less than 1% of the total activity of either complex was present in the spleen, heart and lungs at either 10 or 60 min post injection.
In addition to evaluating the structure/clearance relationship, we also measured the plasma protein binding (PPB) and erythrocyte uptake since these factors modulate the tubular extraction of renal tracers. For example, the high protein binding of 99m Tc-MAG3 relative to 131 I-OIH results in 99m Tc-MAG3 being less available to the OAT1 transporter during the short period of time that the blood is in contact with the basolateral membrane of the renal tubules as it transits the kidney. In consequence, 131 I-OIH is extracted more rapidly by the kidney than 99m Tc-MAG3 [41] . Other important modulators of renal transport include the affinity of tracers for plasma proteins and the affinity for the OAT1 transporter. Tracers that are loosely bound to plasma proteins are more available to the OAT1 transporter than tracers with a high plasma protein binding affinity. The relative low binding affinity of 131 I-OIH and 99m Tc-MAG3 for plasma proteins is illustrated by their high clearance rates and by the fact that the plasma protein binding of both tracers can be reduced 40-50% simply by an infusion of mannitol [42] . The major factor affecting tubular extraction is affinity for the OAT1 transporter. Constant infusion of competitive inhibitors of the OAT1 transporter depress the clearance and extraction efficiency of 99m Tc-MAG3 to a greater extent than 131 I-OIH and help explain the more rapid clearance of 131 I-OIH compared to 99m Tc-MAG3 [42, 43] . In our study, PPB was 21% for 99m Tc(CO) 3 (ADA), 40% for 99m Tc(CO) 3 (HDA) and 61% for 99m Tc(CO) 3 (FEDA) (Figure 4 ) compared to 67% for 99m Tc(CO) 3 (NTA) [22] . The erythrocyte uptake was 12% for 99m Tc(CO) 3 (ADA), 26% for 99m Tc(CO) 3 (HDA) and 20% for 99m Tc(CO) 3 (FEDA) compared to 7% for 99m Tc(CO) 3 (NTA) [22] . In spite of differences in protein binding and erythrocyte uptake, the percent dose in the urine at 10 and 60 minutes for all four tracers was comparable to that for 131 I-OIH. This similarity suggests that, for these tracers, a low binding affinity for plasma proteins and a relatively high binding affinity for the OAT1 transporter are the dominant factors affecting tubular transport.
The urine from rats that received the bolus injection of 18.5 MBq of each of the new 99m Tc(CO) 3 tracers was analyzed by radio-HPLC to determine the in vivo metabolic stability of the complexes. Figure 5 shows typical HPLC traces of analyzed urine and the corresponding injected complex. The corresponding reference HPLC traces demonstrate that all three complexes ( 99m Tc-2 to 99m Tc-4) were excreted unchanged in urine.
Our biodistribution results indicate that all three 99m Tc(CO) 3 (ADA), 99m Tc(CO) 3 (HDA) and 99m Tc(CO) 3 (FEDA) radiotracers exhibit a rapid renal extraction rate, practically identical to that of 99m Tc(CO) 3 (NTA) despite a monoanionic charge and the absence of a negatively charged dangling carboxyl group. Decades of studies of 99m Tc V O renal agents indicated an uncoordinated negative carboxyl group (often in a dangling chain) appeared to be the key factor favoring a high rate of renal extraction [14] . In contrast, our present results lead to the conclusion that the primary factor responsible for the favorable pharmacokinetic properties of 99m Tc-2, 99m Tc-3 and 99m Tc-4 resides chiefly within the [ 99m Tc(CO) 3 (N(CH 2 CO 2 ) 2 )] − inner coordination sphere and much less so in the dangling group. Accordingly, the dangling group may accommodate a wider variety of chemical groups to provide additional functionality to the renal tracers, with the expectation that their pharmacokinetic properties will largely be maintained as long as the [ 99m Tc(CO) 3 (N(CH 2 CO 2 ) 2 )] − moiety is preserved. Nevertheless, the electron-donating properties of the dangling group also still must be taken into consideration when designing a renal tracer because 99m Tc(CO) 3 (NTA) had a significantly higher rate of renal excretion in rats compared to the 99m Tc(CO) 3 (NDAP) tracer [NDAP = nitrilodiacetic-propionic acid] which differs from 99m Tc(CO) 3 (NTA) only in having a more electron-donating propionate pendant group instead of the acetate pendant group in 99m Tc(CO) 3 (NTA) [44] .
Finally, the uncharged fluoroethyl pendant group of 99m Tc(CO) 3 (FEDA) provides a potentially important route to the synthesis of a structurally analogous rhenium- 
Conclusions
A new series of 99m Tc(CO) 3 (NTA) analogs with uncharged pendant groups has been developed to assess the importance of the negatively charged uncoordinated group in the renal tracers for tubular secretion. Three new complexes, 99m Tc(CO) 3 
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